[HIV virus infection and the perinatal period] NLM AIDSLINE Important note: Information in this article was accurate in 1988. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


[HIV virus infection and the perinatal period]

Rev Med Interne. 1987 Nov-Dec;8(5):463-5. Unique Identifier : AIDSLINE MED/88177625
Henrion R; Sereni D; Maternite Port-Royal, Paris.

Abstract: The incidence of HIV infection in women is increasing steadily. It has been estimated that between 30,000 and 40,000 French women in child-bearing age are seropositive for HIV. The risk of a seropositive woman transmitting the virus to her child is 40-50 p. 100, and the child will often develop AIDS during the first two years of life. For this reason, seropositive women should be dissuaded to become pregnant or the pregnancy should be interrupted within the normal time limits. Since no effective treatment of AIDS is available at present, prevention is of paramount importance. It consists of detecting seropositive women and above all fighting against intravenous drug addiction and spreading information on the risk of contamination by sexual intercourse.
Keywords: Acquired Immunodeficiency Syndrome/CONGENITAL/*TRANSMISSION English Abstract Female Human HIV Seropositivity Infant, Newborn Pregnancy *Pregnancy Complications, Infectious Risk Factors JOURNAL ARTICLE

KWDacquiredimmunodeficiencysyndrome/congenital/KWDtransmissionenglishabstractfemalehumanhivseropositivityinfant,newbornpregnancyKWDpregnancycomplications,infectiousriskfactorsjournalarticle
880730
M8870475

Copyright © 1988 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1988. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1988. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .